◆ TICKERBASE · US STOCK FINANCIAL DATA LIBRARY

HomeAll stocksCLX › Gross Profit

The Clorox Company (CLX) Gross Profit 2006–TTM

DATA UPDATED 2026-07-19

The Clorox Company annual gross profit for fiscal TTM was $3.0 billion, a decrease of 7.7% from $3.2 billion in fiscal 2025. All figures are reported results from public filings — no estimates or projections.

CLX Annual Gross Profit

Gross Profit (annual)TTM → 2026-03-312025-06-302024-06-302023-06-302022-06-302021-06-302020-06-302019-06-302018-06-302017-06-302016-06-302015-06-302014-06-302013-06-302012-06-302011-06-302010-06-302009-06-302008-06-302007-06-302006-06-30
Gross Profit$3.0B$3.2B$3.0B$2.9B$2.5B$3.2B$3.1B$2.7B$2.7B$2.7B$2.6B$2.5B$2.4B$2.4B$2.3B$2.3B$2.3B$2.3B$2.2B$2.1B$2.0B

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

CLX Quarterly Gross Profit

Gross Profit (quarterly)2026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-30
Gross Profit$722M$722M$596M$924M$744M$738M$807M$884M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

More CLX metrics: Revenue · Operating Income · Net Income · EPS · EBITDA · Free Cash Flow · Shares Outstanding

All CLX financial statements → Interactive CLX charts →

About TickerBase · Data methodology & sources

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.